Refractory splenectomized immune thrombocytopenic purpura: Does vincristine have a role after thrombopoietin receptor agonist failure?

Faculty of Medicine

Assiut University

Refractory splenectomized immune thrombocytopenic purpura: Does vincristine have a role after thrombopoietin receptor agonist failure?

Research Authors
Sawsan M Moeen, Ahmad F Thabet, Mohamed A Morad
Research Date
Research Department
Internal Medicine
Research Journal
The Egyptian Journal of Haematology
Research Member
Sawsan Mohamed Moeen Ibrahim
Research Publisher
Medknow
Research Vol
Volume 47, Issue 4
Research Website
https://scholar.google.com/scholar?oi=bibs&cluster=226425586651640466&btnI=1&hl=en
Research Year
2022
Research_Pages
299-303
Research Abstract

Objective

This study was done to assess the efficacy of vincristine in the treatment of patients with splenectomized chronic ITP who failed TPO-RA therapy as well as their 8-month follow-up following vincristine discontinuation.